Joint Symposium: HTLV-1
Tracks
1
| Tuesday, November 7, 2017 |
| 11:30 AM - 1:00 PM |
| Royal Theatre |
Details
HTLV-1, is a sexually transmitted and blood-borne virus that is related to HIV (formerly called HTLV-3). Endemic foci are present throughout the world; however, prevalence is highest among Aboriginal Australians in central Australia where >50% of adults are infected in some communities. Infection is associated with a rapidly fatal leukaemia, inflammation in various organ systems including the lungs and central nervous system and an impaired immune response to other infections. In central Australia, an inability to control the number of infected peripheral blood lymphocytes increases risk of death, largely due to HTLV-1 associated pulmonary disease. Although HTLV-1 was identified as a priority in the National HIV Strategy, there has been no dedicated funding to characterise the natural history of HTLV-1 infection, or to develop a vaccine, public health response or therapeutic interventions. This symposium will be held to look in greater detail at the issues around HTLV-1. Note: Graham Taylor presents a plenary on this topic on Wednesday 8 November at 10.30am.
Speaker
Attendee1199
Attendee1373
Positive aspects of securing a diagnosis and effective treatment
11:45 AM - 11:55 AMBiography
Attendee1213
Attendee1119
Viral factors that contribute to HTLV-1 persistence
12:05 PM - 12:15 PMBiography
Attendee1234
Attendee995
Attendee1173
Q&A
12:50 PM - 1:00 PMBiography
